6 Feb 2026·Source: The Hindu

5 min

Social IssuesPolity & GovernanceNEWS

India's Health Budget 2026: Increased Allocations, Missed Targets, Mixed Outcomes

Health budget shows increased allocations but falls short of 2.5% of GDP target.

India's health-care allocations for 2026 show a 10% increase, totaling over ₹1.05 lakh crore, but remain at approximately 1.9% of total government expenditure and 0.26% of GDP, missing the 2.5% target set in the National Health Policy of 2017. The Biopharma SHAKTI scheme receives a significant allocation of ₹10,000 crore to transform India into a biologics and biosimilars manufacturing hub. A pan-country clinical trial infrastructure will be created, and new pharmaceutical education institutes will be established.

The government aims to train allied health professionals and care workers. Customs and import duties are reduced for cancer medicines and rare disease treatments. However, funding for the National Health Mission has decreased, raising concerns about uneven improvements in the health sector.

Key Facts

The health-care component of Budget 2026 is a mixed bag.

The total allocation this year is over ₹1.05 lakh crore.

The 2026 health budget is approximately 1.9% of the total government expenditure, and about 0.26% of GDP.

Finance Minister Nirmala Sitharaman fronted the Biopharma SHAKTI scheme, among the projects with the single highest budgetary allocations this year.

This ₹10,000 crore government initiative will transform India into a manufacturing hub for biologics and biosimilars over the next ve years, she said.

A pan-country clinical state-of-the-art trial infras tructure will also be created, through a network of 1,000 accredited clinical trial sites.

The government will set up three new National Institutes of Pharmaceutical Education and Research (NIPER) and modernise seven existing units, besides establishing a se cond NIMHANS campus in north India and two upgraded national mental health institutes.

The government has set itself a target of training one lakh allied health professionals over the next ve years, while another 1.5 lakh care workers will al so be trained to take care of the health needs of the elderly

The government has ex empted 17 cancer medicines and several treat ments for rare diseases from customs and import duties, while also reducing the tax collected at source on medical and educational remittances from 5% to 2%.

10.

Primarily under re was the Union govern ment’s stodgy refusal to increase the allocation for health care to reach 2.5% of GDP by 2025, as committed in the National Health Policy of 2017.

UPSC Exam Angles

GS Paper II: Social Justice and Governance - Health sector policies and programs

Links to Sustainable Development Goals (SDGs), particularly SDG 3 (Good Health and Well-being)

Potential for analytical questions on the effectiveness of government health initiatives

Visual Insights

India's Health Budget 2026: Key Statistics

Key highlights from the 2026 health budget, including total allocation, GDP percentage, and Biopharma SHAKTI scheme allocation.

Total Health Budget Allocation: ₹1.05 lakh crore
Health Expenditure as % of GDP: 0.26%
Biopharma SHAKTI Scheme Allocation: ₹10,000 crore
Health Expenditure as % of Total Government Expenditure: 1.9%

More Information

Background

The concept of a national health policy in India has evolved over several decades. The initial focus was on controlling communicable diseases and establishing basic healthcare infrastructure. Over time, the policy objectives broadened to include universal access to healthcare, improved health outcomes, and reduced inequalities. Key milestones include the Alma Ata Declaration of 1978, which emphasized primary healthcare as the foundation of a national health system. Subsequent national health policies in 1983 and 2002 built upon this foundation, addressing issues such as decentralization, public-private partnerships, and the role of traditional medicine. The National Health Policy 2017 aimed to achieve universal health coverage and increase public health expenditure to 2.5% of GDP by 2025. The legal and constitutional framework for health in India is complex. While health is primarily a state subject under the Seventh Schedule of the Constitution, the central government plays a crucial role in policy formulation, resource allocation, and regulation. Several laws, such as the Clinical Establishments (Registration and Regulation) Act, 2010, aim to ensure quality and standards in healthcare delivery. The Constitution also includes provisions related to public health, such as Article 47, which directs the State to improve public health and nutrition.

Latest Developments

Recent government initiatives have focused on strengthening primary healthcare and expanding health insurance coverage. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) aims to provide health insurance cover to a large section of the population. The establishment of Health and Wellness Centres (HWCs) is another key initiative to improve access to primary healthcare services. There are ongoing debates about the optimal level of public health expenditure and the role of the private sector in healthcare delivery. Some argue for increased public investment to ensure equitable access to healthcare, while others emphasize the efficiency and innovation that the private sector can bring. Institutions like NITI Aayog are actively involved in shaping health policy and promoting evidence-based decision-making. The future outlook for India's health sector includes a continued focus on digital health, telemedicine, and preventive healthcare. The government aims to leverage technology to improve access to healthcare services, particularly in rural and remote areas. Achieving the target of 2.5% of GDP for public health expenditure remains a key challenge.

Frequently Asked Questions

1. What are the key facts about India's Health Budget 2026 that are important for the UPSC Prelims exam?

For Prelims, remember these key facts: The total health-care allocation for 2026 is ₹1.05 lakh crore. This is approximately 1.9% of the total government expenditure and about 0.26% of GDP. The Biopharma SHAKTI scheme has an allocation of ₹10,000 crore. Also note the National Health Policy of 2017 aimed for 2.5% of GDP.

Exam Tip

Focus on the percentages and amounts allocated to different schemes. Pay attention to the target set by the National Health Policy.

2. What is the Biopharma SHAKTI scheme, and why is it important in the context of the 2026 health budget?

The Biopharma SHAKTI scheme is a ₹10,000 crore government initiative aimed at transforming India into a manufacturing hub for biologics and biosimilars. It is important because it received one of the highest budgetary allocations this year, signaling the government's focus on boosting domestic pharmaceutical manufacturing and reducing reliance on imports.

Exam Tip

Remember the scheme's name and its objective. Understand its significance in the context of 'Atmanirbhar Bharat' (self-reliant India).

3. What are the potential implications of the 2026 health budget's allocation falling short of the 2.5% of GDP target?

Falling short of the 2.5% target may hinder the achievement of universal health coverage and other health goals outlined in the National Health Policy. It could lead to slower improvements in health outcomes, particularly in areas like maternal and child health, and may exacerbate existing inequalities in access to healthcare services.

Exam Tip

Consider the impact on Sustainable Development Goals (SDGs) related to health. Think about the ethical implications of underfunding healthcare.

4. Why is the topic of India's Health Budget 2026 in the news recently?

The topic is in the news due to the recent release of the budget and the analysis of its allocations for the health sector. The increased allocation of ₹1.05 lakh crore, along with the missed target of 2.5% of GDP, has sparked discussions and debates among health experts and policymakers.

Exam Tip

Follow news articles and analyses from reputable sources to stay updated on the ongoing discussions.

5. How does the allocation for the National Health Mission (NHM) in the 2026 budget compare to previous years, and what are the potential consequences?

According to the provided information, funding for the National Health Mission has decreased. This raises concerns about uneven improvements in the health sector, as the NHM plays a crucial role in strengthening healthcare infrastructure and service delivery, especially in rural and underserved areas.

Exam Tip

Understand the role and objectives of the National Health Mission. Analyze the potential impact of reduced funding on its various programs.

6. What reforms are needed to improve healthcare financing in India, considering the missed target of 2.5% of GDP?

Reforms could include increasing the overall health budget allocation, improving efficiency in spending, exploring innovative financing mechanisms, and strengthening public-private partnerships. Greater emphasis on preventive healthcare and primary healthcare can also reduce the burden on tertiary care and improve health outcomes.

Exam Tip

Think about long-term solutions and sustainable financing models. Consider the role of technology and innovation in improving healthcare delivery.

Practice Questions (MCQs)

1. Consider the following statements regarding India's health budget for 2026: 1. The total health-care allocation exceeds ₹1.05 lakh crore. 2. The health budget constitutes approximately 2.5% of India's GDP. 3. The Biopharma SHAKTI scheme aims to transform India into a biologics and biosimilars manufacturing hub. Which of the statements given above is/are correct?

A.1 and 2 only
B.1 and 3 only
C.2 and 3 only
D.1, 2 and 3

Show Answer

Answer: B

Statement 1 is CORRECT: India's health-care allocations for 2026 show a 10% increase, totaling over ₹1.05 lakh crore. Statement 2 is INCORRECT: The health budget constitutes approximately 0.26% of GDP, missing the 2.5% target set in the National Health Policy of 2017. Statement 3 is CORRECT: The Biopharma SHAKTI scheme receives a significant allocation of ₹10,000 crore to transform India into a biologics and biosimilars manufacturing hub.

2. Which of the following is NOT a stated objective of the Biopharma SHAKTI scheme mentioned in the news?

A.Transforming India into a biologics manufacturing hub
B.Establishing new pharmaceutical education institutes
C.Creating a pan-country clinical trial infrastructure
D.Providing direct financial assistance to patients

Show Answer

Answer: D

The Biopharma SHAKTI scheme aims to transform India into a biologics and biosimilars manufacturing hub. A pan-country clinical trial infrastructure will be created, and new pharmaceutical education institutes will be established. The scheme does not directly provide financial assistance to patients.

3. Assertion (A): The National Health Mission (NHM) aims to improve health indicators across India. Reason (R): The recent health budget has increased funding for the National Health Mission. In the context of the above statements, which of the following is correct?

A.Both A and R are true, and R is the correct explanation of A
B.Both A and R are true, but R is NOT the correct explanation of A
C.A is true, but R is false
D.A is false, but R is true

Show Answer

Answer: C

Assertion A is TRUE: The National Health Mission (NHM) indeed aims to improve health indicators across India. Reason R is FALSE: According to the news, funding for the National Health Mission has decreased, raising concerns about uneven improvements in the health sector.

4. With reference to the National Health Policy 2017, consider the following statements: 1. It proposed increasing public health expenditure to 2.5% of GDP by 2025. 2. It aims to provide universal health coverage to all citizens. 3. It recommends a shift towards privatization of healthcare services. Which of the statements given above is/are correct?

A.1 and 2 only
B.1 and 3 only
C.2 and 3 only
D.1, 2 and 3

Show Answer

Answer: A

Statement 1 is CORRECT: The National Health Policy 2017 aimed to increase public health expenditure to 2.5% of GDP by 2025. Statement 2 is CORRECT: It aims to provide universal health coverage to all citizens. Statement 3 is INCORRECT: The policy emphasizes strengthening public healthcare services and does not recommend privatization.